Year: 2015
Type: review
Abstract: The vgf gene (non-acronymic) is highly conserved and was identified on the basis of its rapid induction in vitro by nerve growth factor, although can also be induced by brain-derived neurotrophic factor, and glial-derived growth factor. The VGF gene gives rise to a 68 kDa precursor polypeptide, which is induced robustly, relatively selectively and is synthesized exclusively in neuronal and neuroendocrine cells. Post-translational processing by neuroendocrine specific prohormone convertases in these cells results in the production of a number of smaller peptides. The VGF gene and peptides are widely expressed throughout the brain, particularly in the hypothalamus and hippocampus, in peripheral tissues including the pituitary gland, the adrenal glands, and the pancreas, and in the gastrointestinal tract in both the myenteric plexus and in endocrine cells. VGF peptides have been associated with a number of neuroendocrine roles, and in this review, we aim to describe these roles to highlight the importance of VGF as therapeutic target for a number of disorders, particularly those associated with energy metabolism, pain, reproduction, and cognition.
Source: Frontiers in Endocrinology
Authors: Jo E. Lewis, John M. Brameld, Preeti H. Jethwa
Institutions: University of Nottingham, Queen's Medical Centre
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: VGF, neuroendocrine regulation, prohormone convertases, nerve growth factor, brain-derived neurotrophic factor, glial cell line-derived neurotrophic factor, hypothalamus, hippocampus, pituitary gland, adrenal gland, pancreas, gastrointestinal endocrine cells, energy metabolism, pain, reproduction, cognition, therapeutic target
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W1974837024
